Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hydronidone”

16 trials

Showing 16 of 16 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07412236
What this trial is testing

A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.

Who this might be right for
Liver FibrosisLiver Fibrosis in Chronic Hepatitis B
Beijing Continent Pharmaceutical Co, Ltd. 1,208
Early research (Phase 1)Study completedNCT04162821
What this trial is testing

Study on Pharmacokinetics of Hydronidone

Who this might be right for
Pharmacokinetics of Hydronidone
Beijing Continent Pharmaceutical Co, Ltd. 48
Early research (Phase 1)Study completedNCT07295873
What this trial is testing

Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide

Who this might be right for
Chronic Hepatitis B Liver FibrosisDDI (Drug-Drug Interaction)
Beijing Continent Pharmaceutical Co, Ltd. 64
Early research (Phase 1)Study completedNCT07262346
What this trial is testing

The Phase Ⅰd Clinical Trial of Hydronidone Capsules

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 138
Early research (Phase 1)Study completedNCT07471217
What this trial is testing

[¹⁴C] Hydronidone Mass Balance Study

Who this might be right for
Chronic Hepatitis B-related Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 6
Early research (Phase 1)Study completedNCT07263152
What this trial is testing

QTc Assessment in a Single-Dose Study of Hydronidone Capsules

Who this might be right for
Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 48
Early research (Phase 1)Study completedNCT04123769
What this trial is testing

Study on PK of Hydronidone in Patients and Special Population

Who this might be right for
Hepatitis b & Liver Dysfunction
Beijing Continent Pharmaceutical Co, Ltd. 8
Large-scale testing (Phase 3)Study completedNCT05115942
What this trial is testing

Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 248
Large-scale testing (Phase 3)Looking for participantsNCT05905172
What this trial is testing

Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 248
Testing effectiveness (Phase 2)Study completedNCT07364448
What this trial is testing

Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis

Who this might be right for
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 411
Early research (Phase 1)Study completedNCT04124081
What this trial is testing

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

Who this might be right for
Hydronidone
Beijing Continent Pharmaceutical Co, Ltd. 12
Large-scale testing (Phase 3)Study completedNCT07343778
What this trial is testing

A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis

Who this might be right for
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 337
Not applicableStudy completedNCT04125056
What this trial is testing

Study on Hydronidone Capsule BE

Who this might be right for
Healthy
Beijing Continent Pharmaceutical Co, Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02499562
What this trial is testing

A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis

Who this might be right for
Hepatitis B, Chronic
Shanghai Genomics, Inc. 168
Early research (Phase 1)Study completedNCT07394309
What this trial is testing

Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT07417553
What this trial is testing

Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

Who this might be right for
Chronic Hepatitis B-related Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 67

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation